Commercialisation & Outcomes Services

Accelerating patient access to innovative treatments that improve quality of life

ICON delivers Commercialisation & Outcomes services, resources and expertise to identify, generate, synthesize and communicate evidence of treatment value and safety, to help regulators, payers, providers and patients make informed health decisions.

Other Commercialisation and Outcomes Services include:

Real World Evidence Strategy and Analytics

Our global epidemiologists and outcomes researchers employ Real World Intelligence, combining real world data, advanced technology and deep expertise to accelerate market access

Explore

Late Phase Patient and Site Engagement

We understand the unique requirements of managing late phase and post-market studies. Our innovative global research services hubs deliver end-to-end site and patient support and patient engagement.

Explore

Language Services

As the industry’s largest life sciences language services provider, we deliver translations, linguistic validations, and market dominant COA expertise.

Explore

Strategic Regulatory Services

Today’s regulatory landscape is complex and ever-changing. We deliver solutions built on 30+ years of experience navigating global regulatory requirements and emerging issues.

Explore

Mapi Research Trust

ICON is the leading sponsor of Mapi Research Trust, a non-profit organisation dedicated to improving patients’ quality of life by facilitating access to patient-centered outcome information

Explore

Stay Informed with ICON Commercialisation & Outcomes Briefings

Get the information and insights you need to stay fully informed about developments in global healthcare systems, important pricing and reimbursement trends and policies, and advances in key therapeutic areas. Subscribe to our newsletter to receive future issues of our briefing.

Real world evidence is driving healthcare and research discussions and decisions among regulators, payers, providers, and patients. ICON delivers an integrated solution to deliver the value and safety evidence these stakeholders demand.

Resources and expertise to achieve product authorisation, accelerate market access, and drive product adoption

Resources and expertise to achieve product authorisation, accelerate market access, and drive product adoption

Cross functional teams for innovative RWE strategies and late phase research

Cross functional teams for innovative RWE strategies and late phase research

Services built upon the heritage of the industry's most respected health outcomes organisations

Services built upon the heritage of the industry